The cancer Alzheimer's disease paradox

9 hours ago

Epidemiological studies consistently show an inverse correlation between cancer and Alzheimer's disease, meaning cancer patients have a lower risk of Alzheimer's and Alzheimer's patients have a lower risk of cancer.
Both diseases share common risk factors, particularly aging, yet they exhibit reciprocal protective effects, which are unique to Alzheimer's compared to other neurodegenerative conditions.
Personal experience underscores the devastating impact of glioblastoma, illustrating how brain cancer can erode identity similarly to Alzheimer's.
Despite advancements like immune checkpoint inhibitors and anti-amyloid therapies, many cancers remain fatal, and Alzheimer's cognitive decline persists, indicating a need for paradigm shifts.
Potential mechanisms include opposing biological processes: cancer involves cell proliferation and immune evasion, while Alzheimer's involves cell death and immune activation.
Specific molecules like PIN1, amyloid-beta, and APOE4 are implicated in this inverse relationship, suggesting shared pathways with divergent roles.
Research opportunities lie in leveraging large datasets, interdisciplinary collaboration, and AI to uncover actionable therapeutic targets for both diseases.
Bridging cancer and Alzheimer's research could lead to innovative treatments, such as repurposing cancer drugs or using tumor-derived factors like cystatin-C for Alzheimer's.

Hasty Briefsbeta